Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment outcomes and life expectancy news

Show

From To
Infectious and non-infectious lung disease risk increased for those with HIV

HIV is associated with an increased risk of lung disease with infectious and non-infectious causes, US investigators report in the American Journal of Respiratory and Critical Care

Published
29 September 2010
By
Michael Carter
Aging With Complex Chronic Disease: The Wrinkled Face of AIDS

People living with HIV taking combination Antiretroviral Therapy (treatment) are living long enough to experience a diverse array of aging related conditions such as osteoporosis, cardiovascular disease, chronic obstructive pulmonary disease (COPD), renal disease, liver cirrhosis, and cancer.

Published
25 August 2010
From
The Body Pro / GMHC Treatment Issues
Heroin use, AIDS, predict reduced bone mineral density in older men with HIV

Older HIV-positive men have lower bone mineral density than their HIV-negative peers, a US study published in the online edition of AIDS shows. The study population

Published
24 August 2010
By
Michael Carter
Maraviroc potentially of benefit for many patients with late HIV diagnosis

Almost two-thirds of patients whose infection with HIV was diagnosed late had virus that uses the CCR5 co-receptor, and could therefore potentially benefit from taking a treatment

Published
16 August 2010
By
Michael Carter
New diagnoses among over 50s double in England, Wales and Northern Ireland

Almost half of older patients with HIV are diagnosed late, according to a study published in the August 24th edition of AIDS. The study was conducted using

Published
16 August 2010
By
Michael Carter
Lymphocyte count and haemoglobin can predict prognosis of patients starting ART

Measuring total lymphocyte count and anaemia can help predict the prognosis of patients starting antiretroviral therapy in Africa, investigators report in the on-line edition of The Lancet. An

Published
03 August 2010
By
Michael Carter
Outcomes still improving for HIV patients in the UK

Outcomes for HIV-positive patients taking antiretroviral therapy in the UK have improved significantly in recent years, and are projected to continue to do so until at least

Published
02 August 2010
By
Michael Carter
Child mortality falls after mothers receive HIV drugs

Children born to mothers with HIV in a rural district of KwaZulu Natal were 75% less likely to die before the age of five if their mothers

Published
20 July 2010
By
Keith Alcorn
Large-scale impact of ART on mortality in Brazil, South Africa: big successes but mind the gaps

Studies from two developing countries that have prioritised the scale-up of ART further demonstrated the potential for treatment to have a dramatic impact on HIV-related mortality in

Published
20 July 2010
By
Keith Alcorn
CD4 cell count below 500 associated with increased risk of CVD - implications for 'when to start' debate

A low CD4 cell count is a strong, independent risk factor for the development of cardiovascular disease for patients with HIV, investigators from the US

Published
12 July 2010
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.